The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development
Viruses · 16.07.2023 · 15 (7) · 1558
DOI: 10.3390/v15071558 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 16.07.2023. Verfasst von Gergana Zahmanova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Hepatitis E virus, Hepatitis E, Viral Vaccines. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund at the University of Plovdiv, European Union’s Horizon 2020 research and innovation program, European Regional Development Fund.
Abstract (Originalsprache)
Hepatitis E virus (HEV) is one of the leading causes of acute viral hepatitis. Transmission of HEV mainly occurs via the fecal-oral route (ingesting contaminated water or food) or by contact with infected animals and their raw meat products. Some animals, such as pigs, wild boars, sheep, goats, rabbits, camels, rats, etc., are natural reservoirs of HEV, which places people in close contact with them at increased risk of HEV disease. Although hepatitis E is a self-limiting infection, it could also lead to severe illness, particularly among pregnant women, or chronic infection in immunocompromised people. A growing number of studies point out that HEV can be classified as a re-emerging virus in developed countries. Preventative efforts are needed to reduce the incidence of acute and chronic hepatitis E in non-endemic and endemic countries. There is a recombinant HEV vaccine, but it is approved for use and commercially available only in China and Pakistan. However, further studies are needed to demonstrate the necessity of applying a preventive vaccine and to create conditions for reducing the spread of HEV. This review emphasizes the hepatitis E virus and its importance for public health in Europe, the methods of virus transmission and treatment, and summarizes the latest studies on HEV vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.
- Department of Technology Transfer and IP Management, Center of Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria.
- Department of Animal Genetics, Faculty of Veterinary Medicine, Trakia University, 6000 Stara Zagora, Bulgaria.
- Faculty of Sciences, Brigham Young University-Hawaii, Laie, HI 96762, USA.
- Institute of Molecular Biology and Biotechnologies, 4108 Markovo, Bulgaria.
- Department of Infectious Diseases, Pazardzhik Multiprofile Hospital for Active Treatment, 4400 Pazardzhik, Bulgaria.
ORCID-Profile: Gergana Zahmanova, Ivan Minkov, Maria Pishmisheva, Ilia Tsachev, Magdalena Baymakova
Förderung
- Research Fund at the University of Plovdiv
- European Union’s Horizon 2020 research and innovation program
- European Regional Development Fund
Zitieren
APA
Zahmanova, G., Takova, K., Tonova, V., Koynarski, T., Lukov, L. L., Minkov, I., Pishmisheva, M., Kotsev, S., Tsachev, I., Baymakova, M., & Andonov, A. P. (2023). The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development. Viruses, 15(7), 1558. https://doi.org/10.3390/v15071558
Vancouver
Zahmanova G, Takova K, Tonova V, Koynarski T, Lukov LL, Minkov I, et al. The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development. Viruses. 2023;15(7):1558. doi:10.3390/v15071558
BibTeX
@article{Zahmanova2023,
author = {Zahmanova, Gergana and Takova, Katerina and Tonova, Valeria and Koynarski, Tsvetoslav and Lukov, Laura L and Minkov, Ivan and Pishmisheva, Maria and Kotsev, Stanislav and Tsachev, Ilia and Baymakova, Magdalena and Andonov, Anton P},
title = {The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development},
journal = {Viruses},
year = {2023},
volume = {15},
number = {7},
pages = {1558},
doi = {10.3390/v15071558}
}
EUVIMED